Interaction of cyclooxygenase 2 genotype and smoking habit in taiwanese lung cancer patients

Anticancer Research

Volumn 30, Issue 4, 2010, Pages 1195-1199

  Liu, Chin Jung ^a,b   Hsia, Te Chun ^a   Wang, Rou Fen ^a   Tsai, Chia Wen ^b   Chu, Chia Chen ^a,b   Hang, Liang Wen ^a   Wang, Chung Hsing ^a   Lee, Hong Zin ^a,b   Tsai, Ru Yin ^a   Bau, Da Tian ^a,b  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Carcinogenesis; Cox 2; Lung cancer; Polymorphism

Indexed keywords

CYCLOOXYGENASE 2; GENOMIC DNA;

ADULT; ARTICLE; CANCER PATIENT; CANCER RISK; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETIC RISK; GENOTYPE; HEREDITY; HIGH RISK PATIENT; HUMAN; INTRON; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SMOKING HABIT; TAIWAN;

CASE-CONTROL STUDIES; CYCLOOXYGENASE 2; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SMOKING; TAIWAN; TUMOR MARKERS, BIOLOGICAL;

EID: 77953747411     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Chiu HF, Cheng MH, Tsai SS, Wu TN, Kuo HW and Yang CY: Outdoor air pollution and female lung cancer in Taiwan. Inhal Toxicol 18: 1025-1031, 2006.
2. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005.
3. Shields PG and Harris CC: Cancer risk and low-penetrance susceptibility genes in gene-environment interactions. J Clin Oncol 75: 2309-2315, 2000.
4. Shields PG: Molecular epidemiology of smoking and lung cancer. Oncogene 27: 6870-6876, 2002.
5. Jemal A, Siegel R, Ward E, Murray T, Xu J and Thun MJ: Cancer statistics, 2007. CA Cancer J Clin 57: 43-66, 2007.
6. Yang L, Parkin DM, Ferlay J, Li L and Chen Y: Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol Biomarkers Prev 14: 243-250, 2005.
7. Zhang H and Cai B: The impact of tobacco on lung health in China. Respirology 8: 17-21, 2003.
8. Fitzpatrick FA: Inflammation, carcinogenesis and cancer. Int Immunopharmacol 1: 1651-1667, 2001.
9. Godschalk R, Nair J, van Schooten FJ, Risch A, Drings P, Kayser K, Dienemann H and Bartsch H: Comparison of multiple DNA adduct types in tumor adjacent human lung tissue: effect of cigarette smoking. Carcinogenesis 23: 2081-2086, 2002.
10. Boffetta P, Ye W, Boman G and Nyren: Lung cancer risk in a population-based cohort of patients hospitalized for asthma in Sweden. Eur Respir J 79: 127-133, 2002.
11. Sasco AJ, Merrill RM, Dari I, Benhaim-Luzon V, Carriot F, Cann CI and Bartal M: A case-control study of lung cancer in Casablanca, Morocco. Cancer Causes Control 13: 609-616, 2002.
12. Matanic D, Beg-Zec Z, Stojanovic D, Matakoric N, Flego V and Milevoj-Ribic F: Cytokines in patients with lung cancer. Scand J Immunol 57: 173-178, 2003.
13. Koki A, Khan NK, Woerner BM, Dannenberg AJ, Olson L, Seibert K, Edwards D, Hardy M, Isakson P and Masferrer JL: Cyclooxygenase-2 in human pathological disease. Adv Exp Med Biol 507: 177-184, 2002.
14. Hida T, Yatabe Y, Achiwa H, Muramatsu H, Kozaki K, Nakamura S, Ogawa M, Mitsudomi T, Sugiura T and Takahashi T: Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res 58: 3761-3764, 1998.
15. DeWitt DL: Prostaglandin endoperoxide synthase: regulation of enzyme expression. Biochim Biophys Acta 1083: 121-134, 1991.
16. Kujubu DA, Reddy ST, Fletcher BS and Herschman HR: Expression of the protein product of the prostaglandin synthase-2/TIS10 gene in mitogen-stimulated Swiss 3T3 cells. J Biol Chem 268: 5425-5430, 1993.
17. Reddy ST and Herschman HR: Ligand-induced prostaglandin synthesis requires expression of the TIS10/PGS-2 prostaglandin synthase gene in murine fibroblasts and macrophages. J Biol Chem 269: 15473-15480, 1994. (Pubitemid 24202129)
18. Kawata R, Reddy ST, Wolner B and Herschman HR: Prostaglandin synthase 1 and prostaglandin synthase 2 both participate in activation-induced prostaglandin D2 production in mast cells. J Immunol 155: 818-825, 1995.
19. Anto RJ, Mukhopadhyay A, Shishodia S, Gairola CG and Aggarwal BB: Cigarette smoke condensate activates nuclear transcription factor-kappaB through phosphorylation and degradation of IkappaB(alpha): correlation with induction of cyclooxygenase-2. Carcinogenesis 23: 1511-1518, 2002. (Pubitemid 35012432)
20. Hida T, Kozaki K, Ito H, Miyaishi O, Tatematsu Y, Suzuki T, Matsuo K, Sugiura T, Ogawa M, Takahashi T and Takahashi T: Significant growth inhibition of human lung cancer cells both in vitro and in vivo by the combined use of a selective cyclooxygenase 2 inhibitor, JTE-522, and conventional anticancer agents. Clin Cancer Res 8: 2443-2447, 2002.
21. Castelao JE, Bart RD, 3rd, DiPerna CA, Sievers EM and Bremner RM: Lung cancer and cyclooxygenase-2. Ann Thorac Surg 76: 1327-1335, 2003.
22. Papafili A, Hill MR, Brull DJ, McAnulty RJ, Marshall RP, Humphries SE and Laurent GJ: Common promoter variant in cyclooxygenase-2 represses gene expression: evidence of role in acute-phase inflammatory response. Arterioscler Thromb Vasc Biol 22: 1631-1636, 2002.
23. Cok SJ and Morrison AR: The 3′-untranslated region of murine cyclooxygenase-2 contains multiple regulatory elements that alter message stability and translational efficiency. J Biol Chem 276: 23179-23185, 2001.
24. Hu Z, Miao X, Ma H, Wang X, Tan W, Wei Q, Lin D and Shen H: A common polymorphism in the 3′UTR of cyclooxygenase 2/prostaglandin synthase 2 gene and risk of lung cancer in a Chinese population. Lung Cancer 48: 11-17, 2005. (Pubitemid 40380996)
25. Campa D, Zienolddiny S, Maggini V, Skaug V, Haugen A and Canzian F: Association of a common polymorphism in the cyclooxygenase 2 gene with risk of non-small cell lung cancer. Carcinogenesis 25: 229-235, 2004. (Pubitemid 38239806)
26. Yang L, Parkin DM, Li L and Chen Y: Time trends in cancer mortality in China: 1987-1999. Int J Cancer 706: 771-783, 2003.